Liwen Guo

No. 1 Banshan East Road
Hangzhou, 310022, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Identification of CD4+ T Cell-Related Biomarkers and Mechanisms for Hepatoma.

Identification of CD4+ T Cell-Related Biomarkers and Mechanisms for Hepatoma.

Journal: Combinatorial chemistry & high throughput screening
Published: September 15, 2025

Chinese expert consensus on transradial access in percutaneous peripheral interventions.

Chinese expert consensus on transradial access in percutaneous peripheral interventions.

Journal: Journal of interventional medicine
Published: August 24, 2023

Targeting Yes1 Associated Transcriptional Regulator Inhibits Hepatocellular Carcinoma Progression and Improves Sensitivity to Sorafenib: An in vitro and in vivo Study.

Targeting Yes1 Associated Transcriptional Regulator Inhibits Hepatocellular Carcinoma Progression and Improves Sensitivity to Sorafenib: An in vitro and in vivo Study.

Journal: OncoTargets and therapy
Published: February 12, 2020

Atorvastatin potentiates the chemosensitivity of human liver cancer cells to cisplatin via downregulating YAP1.

Atorvastatin potentiates the chemosensitivity of human liver cancer cells to cisplatin via downregulating YAP1.

Journal: Oncology letters
Published: February 10, 2020

Electromagnetic navigation to assist with computed tomography-guided thermal ablation of liver tumors.

Electromagnetic navigation to assist with computed tomography-guided thermal ablation of liver tumors.

Journal: Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy
Published: August 09, 2019

125I suppressed the Warburg effect viaregulating miR-338/PFKL axis in hepatocellular carcinoma.

125I suppressed the Warburg effect viaregulating miR-338/PFKL axis in hepatocellular carcinoma.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 19, 2019

Knockdown of TAZ modifies triple-negative breast cancer cell sensitivity to EGFR inhibitors by regulating YAP expression.

Knockdown of TAZ modifies triple-negative breast cancer cell sensitivity to EGFR inhibitors by regulating YAP expression.

Journal: Oncology reports
Published: January 12, 2016

YAP/TAZ for cancer therapy: opportunities and challenges (review).

YAP/TAZ for cancer therapy: opportunities and challenges (review).

Journal: International journal of oncology
Published: December 02, 2014

Giant appendiceal neurofibroma in von Recklinghausen's disease: A case report and literature review.

Giant appendiceal neurofibroma in von Recklinghausen's disease: A case report and literature review.

Journal: Oncology letters
Published: January 22, 2014
Showing 1-9 of 9

Last Updated: 09/26/2026